Treatment of keratoconus
Keratoconus is an evolutive progressive disease. The cornea (the transparent outer part of the eye) which is normally round and domed becomes thinner to form a cone. The irregularity of the cornea causes blurred vision.
The cross-Linking (CXL) treatment strengthens the biomechanics of the cornea and stops the progression of the keratoconus in the early phases of the disease. This technique involves applying a photo-sensitive solution (riboflavin or vitamin B2) to the cornea and exposing it to a low dose of ultraviolet rays. The solution then reacts with the ultraviolet light to create new collagen bonds across the cornea.
On the day of your procedure, you will spend an hour in the clinic. On arrival, you will receive a pre-medication and put on a sterile outfit.
During your procedure
It takes place in a lying position on a stryker ophthalmology chair. After following strict aseptic regulations, we perform topical anesthesia with a few drops of eye drops. The procedure lasts around 30 minutes. It consists of two stages:
- Putting drops of solution into the eye (vitamin B2)
- Application of UVA light to the eye
After your procedure
It is necessary to be met by an accompanying person on leaving as it is advisable to rest with eyes closed during the first hours following treatment.
You will start an antibiotic and anti-inflammatory treatment on the evening of the procedure as indicated on the prescription.
During the week following the operation, it is essential not to expose your eyes to hazardous situations (dust in the air, for example). You must avoid all situations that may expose your eyes to micro-organisms (e.g. bacteria, viruses, fungi). Strict hygiene rules should be observed, including washing of hands before the installation of eye drops. You should avoid shocks to your eyes and even restrain from rubbing your eyes.
Dr. Donate will provide your post-operative follow-up. It will consist of a check-up visit during the days following the intervention.